Delivery Order SPE2DB20D2014-SPE2DB24FB92R
Award Date 5/15/24
Potential Completion Date 6/6/24
Potential Value $52K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S to the Defense Logistics Agency (DLA). The $25,920.62 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $69,234.85 firm fixed-price delivery order contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025 and was awarded on June 25, 2025. It is not designated as a set-aside contract, indicating open...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The $12,960.30 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S to the Defense Logistics Agency (DLA). The $12,345.35 firm fixed-price delivery order has a completion date of February 4, 2022. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. The IDC enables...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order valued at $83,081.82 for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, with an ultimate completion date of June 13, 2025. The contract is a Firm Fixed Price arrangement and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,920.62 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Department of Defense (DoD) and its Medical Supply Chain agency. The ceiling value of the firm-fixed-price delivery order is $51,841.24, with a period of performance through June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the Defense...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The $25,920.62 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of September 26, 2024. This contract is not set aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The $27,693.94 delivery order contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price pricing type. The contract is not set-aside and has an ultimate completion date of June 27, 2025. AmerisourceBergen also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,846.97 firm fixed-price delivery order contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. The contract has an ultimate completion date of July 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB92RDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division provides for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $51,841.24 firm fixed price delivery order contract has a completion date of June 6, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen serves as the primary supplier of a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has no set-aside designation.
Generated 8/14/24, 10:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.8k | 5/15/24 |